Financial Advocates Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-691
| Closed | -$438K | – | 714 |
|
|
2025
Q1 | $438K | Buy |
691
+26
| +4% | +$16.5K | 0.03% | 452 |
|
|
2024
Q4 | $474K | Buy |
+665
| New | +$474K | 0.03% | 465 |
|
|
2024
Q2 | – | Sell |
-392
| Closed | -$377K | – | 778 |
|
|
2024
Q1 | $377K | Sell |
392
-1
| -0.3% | -$962 | 0.02% | 520 |
|
|
2023
Q4 | $345K | Buy |
393
+80
| +26% | +$70.3K | 0.02% | 509 |
|
|
2023
Q3 | $258K | Buy |
313
+4
| +1% | +$3.29K | 0.02% | 567 |
|
|
2023
Q2 | $222K | Sell |
309
-90
| -23% | -$64.7K | 0.02% | 615 |
|
|
2023
Q1 | $328K | Buy |
+399
| New | +$328K | 0.02% | 521 |
|
|
2022
Q2 | – | Sell |
-287
| Closed | -$200K | – | 769 |
|
|
2022
Q1 | $200K | Buy |
+287
| New | +$200K | 0.01% | 684 |
|
|
2021
Q4 | – | Sell |
-492
| Closed | -$298K | – | 799 |
|
|
2021
Q3 | $298K | Buy |
492
+47
| +11% | +$28.5K | 0.02% | 616 |
|
|
2021
Q2 | $248K | Buy |
+445
| New | +$248K | 0.02% | 636 |
|